1
Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation
Condition(s):HER2-Negative Breast CancerLast Updated:September 13, 2019Not yet recruiting
Pembrolizumab: 1187 Clinical Trials, Page 1 of 119
Hide Studies Not Open or Pending
2
Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Condition(s):Stage IV Melanoma; Stage III Melanoma; Advanced MelanomaLast Updated:July 1, 2019Recruiting
3
Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer
Condition(s):Small Cell Lung CancerLast Updated:June 7, 2018Completed
4
Trial of Pembrolizumab in Cancer of Unknown Primary
Condition(s):Cancer of Unknown Primary SiteLast Updated:March 1, 2019Recruiting
5
Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA
Condition(s):Immunotherapy With Pembrolizumab for Nasopharyngeal Carcinoma PatientsLast Updated:June 1, 2018Not yet recruiting
6
Pembrolizumab-PET Imaging
Condition(s):Melanoma; Non-small Cell Lung CancerLast Updated:October 2, 2019Active, not recruiting
7
Pembrolizumab in Refractory Advanced Esophageal Cancer
Condition(s):Esophageal Cancer; Squamous Cell Esophagus Cancer; Adenocarcinoma EsophagusLast Updated:May 20, 2019Active, not recruiting
8
Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning
Condition(s):Prostate CancerLast Updated:December 16, 2019Not yet recruiting
9
LITT and Pembrolizumab in Recurrent Brain Metastasis
Condition(s):Melanoma; Non-small Cell Lung Carcinoma (NSCLC); Renal Cell Carcinoma (RCC); Brain MetastasesLast Updated:January 6, 2020Not yet recruiting
10
Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab
Condition(s):Transitional Cell Carcinoma of the Bladder; BiomarkersLast Updated:February 11, 2019Recruiting